Reduction in unnecessary chlamydia screening among older women at title X-funded family planning sites following a structural intervention-san Francisco, 2009

Sexually Transmitted Diseases

Volumn 38, Issue 2, 2011, Pages 127-129

  Bernstein, Kyle T ^a   Marcus, Julia L ^a   Snell, Ameera ^a   Liska, Sally ^a   Rauch, Leah ^a   Philip, Susan S ^a  

^a SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIUM IDENTIFICATION; CHLAMYDIASIS; COST CONTROL; DIAGNOSTIC TEST; DISEASE SURVEILLANCE; FAMILY PLANNING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; SCREENING TEST; UNITED STATES;

ADULT; AGE DISTRIBUTION; AMBULATORY CARE FACILITIES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COST-BENEFIT ANALYSIS; FAMILY PLANNING SERVICES; FEMALE; FINANCING, GOVERNMENT; HUMANS; MASS SCREENING; SAN FRANCISCO; UNITED STATES; WOMEN'S HEALTH; YOUNG ADULT;

EID: 78751644824     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3182027994     Document Type: Article

References (13)

1. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2008. Atlanta, GA: Department of Health and Human Services, 2009.
2. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55(RR-11):1-100.
3. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2007 supplement, Chlamydia prevalence mo-nioring project annual report 2007. Atlanta, GA: US Department of Health and Human Services, 2009.
4. Marrazzo JM, Celum CL, Hillis SD, et al. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy. Sex Transm Dis 1997; 24:131-141.
5. Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med 1998; 128:277-284.
6. Wong W. STD Program capacity and preparedness in the United States: Results of a national survey, 2009. In: National Coalition of STD Directors 13th Annual Meeting; October 27-30, 2009; Washington, DC.
7. Clinical Laboratory Fee Schedule. 2010. Available at: http:// www.cms.gov/apps/ama/license.asp?file=/ClinicalLabFeeSched/ downloads/10CLAB. zip. Accessed April 7, 2010.
8. Honey E, Augood C, Templeton A, et al. Cost effectiveness of screening for Chlamydia trachomatis: A review of published studies. Sex Transm Infect 2002; 78:406-412.
9. Bixby Center for Global Reproductive Health, UCSF. Family PACT Program report, FY 07/08. San Francisco, CA: UCSF, 2009.
10. Tao G, Branson BM, Anderson LA, et al. Do physicians provide counseling with HIV and STD testing at physician offices or hospital outpatient departments? AIDS 2003; 17:1243-1247.
11. Bull SS, Rietmeijer C, Fortenberry JD, et al. Practice patterns for the elicitation of sexual history, education, and counseling among providers of STD services: Results from the gonorrhea community action project (GCAP). Sex Transm Dis 1999; 26:584-589.
12. STD Control Section. San Francisco sexually transmitted disease annual summary, 2008. San Francisco, CA: San Francisco Department of Public Health, 2009.
13. Centers for Disease Control and Prevention. Chlamydia screening among sexually active young female enrollees of health plans- United States, 2000-2007. MMWR Morb Mortal Wkly Rep 2009; 58:362-365.